Team
The people behind Esma Bio.
Esma Bio is built by a team focused on translating a precision approach to endometriosis into a real therapeutic.
Nermin Ibreljic, PhD
Founder & CEO
Nermin Ibreljic founded Esma Bio to bring a precision, lesion-selective approach to endometriosis and leads the company's scientific vision and strategy.
Jon Einarsson, MD, PhD
Scientific Advisor
Jon Einarsson advises Esma Bio on the clinical and translational direction of its targeted therapeutic platform for endometriosis.
Dr. Diana Monsivais
Research Collaborator
Diana Monsivais leads the Monsivais Lab, an academic research collaborator advancing the science of endometriosis.
Carl Lawton, PhD
Scientific Advisor
Carl Lawton advises Esma Bio on the scientific development of its targeted therapeutic platform for endometriosis.
Collaborators
Research collaborations
Esma Bio works alongside leading academic laboratories advancing the science of women's health.
Monsivais Lab
Dr. Diana Monsivais · Baylor College of Medicine
The Monsivais Lab studies the cell-signaling biology of the endometrium — including the TGF-β pathways disrupted in endometriosis — to understand how the uterine lining is remodeled in health and disease. Their mechanistic insights into endometriotic lesion biology inform Esma Bio's understanding of the disease processes its therapeutic approach is designed to address.